Demonstration by Infra-Red Imaging of a Temperature Control Defect in a Decompression Sickness Model Testing Minocycline
The prevention, prognosis and resolution of decompression sickness (DCS) are not satisfactory. The etiology of DCS has highlighted thrombotic and inflammatory phenomena that could cause severe neurological disorders or even death. Given the immunomodulatory effects described for minocycline, an anti...
Main Authors: | Anne-Virginie Desruelle, Pierre Louge, Simone Richard, Jean-Eric Blatteau, Sandrine Gaillard, Sébastien De Maistre, Hélène David, Jean-Jacques Risso, Nicolas Vallée |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphys.2019.00933/full |
Similar Items
-
Therapeutic management of severe spinal cord decompression sickness in a hyperbaric center
by: Benjamin Simonnet, et al.
Published: (2023-09-01) -
Thirty-five Day Fluoxetine Treatment Limits Sensory-Motor Deficit and Biochemical Disorders in a Rat Model of Decompression Sickness
by: Caroline Cosnard, et al.
Published: (2017-09-01) -
Cecal Metabolomic Fingerprint of Unscathed Rats: Does It Reflect the Good Response to a Provocative Decompression?
by: Anne-Virginie Desruelle, et al.
Published: (2022-05-01) -
Tirofiban, a Glycoprotein IIb/IIIa Antagonist, Has a Protective Effect on Decompression Sickness in Rats: Is the Crosstalk Between Platelet and Leukocytes Essential?
by: Kate Lambrechts, et al.
Published: (2018-07-01) -
Fluoxetine protection in decompression sickness in mice is enhanced by blocking TREK-1 potassium channel with the spadin antidepressant.
by: Nicolas eVallée, et al.
Published: (2016-02-01)